Skip to main content
SP5007,674.37+0.43%DOW53,277.01+0.98%NASDAQ26,180.46+0.43%BTC$77,812.00+5.53%ETH$2,513.75+7.22%GOLD$4,661.60+1.97%OIL$86.64-0.22%
Smart Investors Daily
Sign InSign Up Free
HC

NASDAQ · HCAT

Health Catalyst, Inc.

Healthcare · Medical - Healthcare Information Services

$1.53

Down-$0.10 (-6.13%)

Updated Aug 22, 2026, 1:07 PM

SID Score

3.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
181.07M
P/E ratio
-1.78
Dividend yield
0.00%
52-week range
$0.96 – $3.80
Volume
1.06M
Avg. volume
637.29K

Price performance

HCAT price history

1M range · 21 trading sessions · Daily adjusted prices

HCAT closed at $1.53 after 21 trading sessions, down 26.44% for the selected period.

Last close
$1.53
Period change
-26.44%
Period low
$1.53
Period high
$2.39
Daily close
View OHLC price history
HCAT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 21, 2026$1.61$1.61$1.53$1.531.06M
Aug 20, 2026$1.68$1.715$1.63$1.63523.38K
Aug 19, 2026$1.72$1.80$1.69$1.69720.83K
Aug 18, 2026$1.70$1.78$1.70$1.71354.04K
Aug 17, 2026$1.82$1.8501$1.695$1.70570.22K
Aug 14, 2026$1.76$1.885$1.76$1.85919.7K
Aug 13, 2026$1.75$1.855$1.73$1.751.52M
Aug 12, 2026$1.71$1.82$1.71$1.791.24M
Aug 11, 2026$1.68$1.845$1.68$1.762.05M
Aug 10, 2026$1.71$1.7988$1.69$1.721.04M
Aug 7, 2026$1.855$1.87$1.66$1.733.05M
Aug 6, 2026$2.39$2.40$2.22$2.312.27M
Aug 5, 2026$2.30$2.395$2.25$2.39910.46K
Aug 4, 2026$2.23$2.28$2.22$2.28471.65K
Aug 3, 2026$2.15$2.28$2.15$2.21744.96K
Jul 31, 2026$2.09$2.12$2.045$2.09398.72K
Jul 30, 2026$2.16$2.19$2.035$2.08501.28K
Jul 29, 2026$2.14$2.25$2.115$2.16794.4K
Jul 28, 2026$2.10$2.18$2.08$2.14298.51K
Jul 27, 2026$2.08$2.18$2.08$2.15369.19K
Jul 24, 2026$2.01$2.105$2.01$2.08423.78K

Latest HCAT news

The latest Smart Investors Daily articles mentioning HCAT.

Stock researchCompany · Overview

HCAT research

Overview

Company profile and research snapshot.

Company profile

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$4.25
Implied upside
—
Analysts
—
HCAT recent ratings
DateFirmRatingTarget
Aug 21, 2026Canaccord GenuityHold—
Aug 13, 2026Wells FargoEqual-Weight—
Aug 11, 2026CitigroupNeutral—
Jul 21, 2026Canaccord GenuityBuy—
Jun 26, 2026Wells FargoEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 15, 2026

5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call

Health Catalyst’s second quarter was marked by a notable decline in sales, which management attributed primarily to the ongoing impact of client migrations and a reduction in lower-margin services. The company’s decision to divest Vitalware, its revenue cycle management business, was described by CEO Ben Albert as necessary to focus on areas of highest conviction, despite the near-term revenue impact. Albert acknowledged the structural challenges facing health systems and emphasized that the div

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By